82 parallel-computing "Institute of Computer Science" Postdoctoral positions at Northeastern University
Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
will be in Professor Hai-Ping Cheng research group as part of Northeastern’s broad Quantum Materials and Sensing Institute (QMSI) that includes the Experiential Quantum Advancement Laboratories (EQUAL
-
microfluidics channels experimentally. The particle dynamics under solute concentration gradient will be analyzed and new methods of manipulating particles in complex geometries will be developed. Application
-
About the Opportunity JOB SUMMARY The Postdoctoral Research Fellow will conduct independent and collaborative research at the intersection of epidemiology, environmental health, biostatistics, and
-
rather than as separate problems, in populations including knee osteoarthritis, ACL injury and reconstruction, patellofemoral pain, and knee replacement. The incumbent leads day-to-day conduct of two
-
facility in Kendall Square. About AstraZeneca At AstraZeneca, we’re dedicated to being a Great Place to Work , where you’re empowered to push the boundaries of science and unleash your entrepreneurial
-
Science, or a closely related field, completed by the start date Knowledge of electromagnetic and photonic device design, micro- and nanofabrication, and optical or electrical characterization of
-
About the Opportunity This job description is intended to describe the general nature and level of work being performed by people assigned to this classification. It is not intended to be construed
-
Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 16 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best
-
Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by
-
on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs